Abuse potential and pharmacological comparison of tramadol and morphine.
The purpose of the study was to assess the abuse potential of the opioid analgesic tramadol. Tramadol (75, 150 and 300 mg), morphine (15 and 30 mg) and placebo were tested intramuscularly in volunteer non-dependent opiate abusers. Subjective, behavioral and miotic changes were assessed prior to dosing and intermittently for 12 h after drug administration. Morphine produced typical subjective effects, opiate identifications and miosis. Tramadol 75 and 150 mg were not different from placebo. Although tramadol 300 mg was identified as an opiate, it produced no other morphine-like effects. These findings suggest that tramadol has a low abuse potential by the parenteral route.
Preston
K L
KL
Department of Medicine, Francis Scott Key Medical Center, Baltimore, MD 21224.
Jasinski
D R
DR
Testa
M
M
D000328:Adult; D001143:Arousal / Q000187:drug effects*; D004305:Dose-Response Relationship, Drug; D006801:Humans; D008297:Male; D008875:Middle Aged; D009020:Morphine; D009460:Neurologic Examination; D009293:Opioid-Related Disorders / Q000523:psychology* / Q000534:rehabilitation; D012025:Reflex, Pupillary / Q000187:drug effects; D012718:Set, Psychology; D014147:Tramadol
D014147:Tramadol; D009020:Morphine